Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gadner

Showing results (331-340 of 363) with videos related to

Pageof 37
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93U Creutzig, J Ritter, M Zimmermann, et al.
Pediatric Blood & Cancer|July 28, 2005
Risk factors for diabetes insipidus in langerhans cell histiocytosisN Grois, U Pötschger, H Prosch, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Medical and Pediatric Oncology|May 1, 1997
HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte SocietyJ I Henter, M Aricò, R M Egeler, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Medical and Pediatric Oncology|July 24, 2001
Prognostic significance of DNA di-tetraploidy in neuroblastomaR Ladenstein, I M Ambros, U Pötschger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiationS Burdach, A Meyer-Bahlburg, H J Laws, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
British Journal of Cancer|June 28, 2002
Prognostic impact of chromosomal aberrations in Ewing tumoursC M Hattinger, U Pötschger, M Tarkkanen, et al.
Pageof 37

Showing results (331-340 of 363) with videos related to

Sort By:
Pageof 37
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2001
Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93U Creutzig, J Ritter, M Zimmermann, et al.
Pediatric Blood & Cancer|July 28, 2005
Risk factors for diabetes insipidus in langerhans cell histiocytosisN Grois, U Pötschger, H Prosch, et al.
Blood|October 9, 1998
Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcomeM Schrappe, M Aricò, J Harbott, et al.
Medical and Pediatric Oncology|May 1, 1997
HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte SocietyJ I Henter, M Aricò, R M Egeler, et al.
Klinische Padiatrie|September 23, 1998
Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trialsM Schrappe, A Reiter, G Henze, et al.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Medical and Pediatric Oncology|July 24, 2001
Prognostic significance of DNA di-tetraploidy in neuroblastomaR Ladenstein, I M Ambros, U Pötschger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
High-dose therapy for patients with primary multifocal and early relapsed Ewing's tumors: results of two consecutive regimens assessing the role of total-body irradiationS Burdach, A Meyer-Bahlburg, H J Laws, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998
Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor RegistryR Ladenstein, T Philip, C Lasset, et al.
British Journal of Cancer|June 28, 2002
Prognostic impact of chromosomal aberrations in Ewing tumoursC M Hattinger, U Pötschger, M Tarkkanen, et al.
Pageof 37